John C. Byrd - Publications, H-index & Citations

John C. Byrd

The Ohio State University Comprehensive Cancer Center

61H指数

253论文数

1.7W被引数

收录论文 52

发表时间

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples 临床相关样本中酶法和亚硫酸氢盐DNA甲基化分析的全面比较

Clinical Epigenetics

IF4.4

2025-10-05

OAAI

Barrett Nuttall; Daniel L. Karl; Kathleen Burke; Megan Callahan; Kerrin Mendler; Pablo Cingolani; Steven Criscione; Serhiy Naumenko; Elena Bibikova; Veerendra Munugalavadla; John C. Byrd; Richard R. Furman; Jennifer R. Brown; Andrew Mortlock; Brian A. Dougherty; J. Carl Barrett; Maurizio Scaltriti; James Hadfield

Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia

HEMATOLOGICAL ONCOLOGY

IF3.9

2024-12-23

PREAI

Bibikova, Elena; Parsa, Sara; Floren, Muskan; Law, Brian; Clevenger, Tracy; Cheung, Jean; De Jesus, Gary; Burke, Kathleen; Gulrajani, Michael; Yamaguchi, Kyoko; Do, Phuong; Dougherty, Brian; Whitston, David; Brock, Graham; Munugalavadla, Veerendra; Frigault, Melanie M.; Hartmann, Tanja N.; Byrd, John C.; Furman, Richard R.; Brown, Jennifer R.; Covey, Todd; Mortlock, Andrew

Development of ZE66-0205, a Novel MALT1 Degrader for Treatment of B-Cell Malignancies ZE66-0205的开发，一种用于治疗B细胞恶性疾病的新型MALT1降解剂

BLOOD

IF23.1

2024-11-05

PREAI

Elgamal, Sara; Furby, Casie; Long, Marissa; Fyock, Kaytlynn; Sesterhenn, Thomas M.; Johnstone, Megan E.; Pan, Jianmin; Rai, Shesh N.; Khvat, Alexander; Karapetian, Ruben; Ryakhovskiy, Alexey; Bulanova, Elena; Parchinsky, Vladislav; Savchuk, Nikolay; Dukes, Iain; Burd, Amy; Hertlein, Erin K.; Byrd, John C.

Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats

AAPS JOURNAL

IF3.7

2020-07-16

OAAI

Xie, Zhiliang; Chen, Min; Goswami, Swagata; Mani, Rajes; Wang, Dasheng; Kulp, Samuel K.; Coss, Chris C.; Schaaf, Larry J.; Cui, Fengyu; Byrd, John C.; Jennings, Ryan N.; Schober, Karsten K.; Freed, Carrie; Lewis, Stephanie; Malbrue, Raphael; Muthusamy, Natarajan; Bennett, Chad; Kisseberth, William C.; Phelps, Mitch A.

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2019-02-27

OAAI

Hughes, Jim H.; Phelps, Mitch A.; Upton, Richard N.; Reuter, Stephanie E.; Gao, Yue; Byrd, John C.; Grever, Michael R.; Hofmeister, Craig C.; Marcucci, Guido; Blum, William; Blum, Kristie A.; Foster, David J. R.

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2018-12-27

707

OAAI

Woyach, J. A.; Ruppert, A. S.; Heerema, N. A.; Zhao, W.; Booth, A. M.; Ding, W.; Bartlett, N. L.; Brander, D. M.; Barr, P. M.; Rogers, K. A.; Parikh, S. A.; Coutre, S.; Hurria, A.; Brown, J. R.; Lozanski, G.; Blachly, J. S.; Ozer, H. G.; Major-Elechi, B.; Fruth, B.; Nattam, S.; Larson, R. A.; Erba, H.; Litzow, M.; Owen, C.; Kuzma, C.; Abramson, J. S.; Little, R. F.; Smith, S. E.; Stone, R. M.; Mandrekar, S. J.; Byrd, J. C.

PLK1: a promising and previously unexplored target in double-hit lymphoma

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2018-11-05

OAAI

Hassan, Quais N., II; Alinari, Lapo; Byrd, John C.

Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)

JOURNAL OF GERIATRIC ONCOLOGY

IF2.7

2018-07-01

OAAI

Tallarico, Michael; Foster, Jared C.; Seisler, Drew; Lafky, Jacqueline M.; Hurria, Arti; Jatoi, Aminah; Cohen, Harvey J.; Muss, Hyman B.; Bartlett, Nancy; Cheson, Bruce D.; Jung, Sin-Ho; Leonard, John P.; Byrd, John C.; Nabhan, Chadi

Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

CLINICAL CANCER RESEARCH

IF10.2

2017-02-28

OAAI

Coutre, Steven E.; Furman, Richard R.; Flinn, Ian W.; Burger, Jan A.; Blum, Kristie; Sharman, Jeff; Jones, Jeffrey; Wierda, William; Zhao, Weiqiang; Heerema, Nyla A.; Johnson, Amy J.; Tran, Anh; Zhou, Cathy; Bilotti, Elizabeth; James, Danelle F.; Byrd, John C.; O'Brien, Susan

A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2016-07-22

OAAI

Flinn, Ian W.; Ruppert, Amy S.; Harwin, William; Waterhouse, David; Papish, Steven; Jones, Jeffrey A.; Hainsworth, John; Byrd, John C.

A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy

ANNALS OF HEMATOLOGY

IF2.4

2016-04-27

OAAI

Awan, Farrukh T.; Jones, Jeffrey A.; Maddocks, Kami; Poi, Ming; Grever, Michael R.; Johnson, Amy; Byrd, John C.; Andritsos, Leslie A.

Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia

LEUKEMIA

IF13.4

2015-10-07

OAAI

Rogers, K. A.; Ruppert, A. S.; Bingman, A.; Andritsos, L. A.; Awan, F. T.; Blum, K. A.; Flynn, J. M.; Jaglowski, S. M.; Lozanski, G.; Maddocks, K. J.; Byrd, J. C.; Woyach, J. A.; Jones, J. A.

Population pharmacokinetic-pharmacodynamic (PKPD) modeling of ibrutinib in patients with B-cell malignancies.

CLINICAL CANCER RESEARCH

IF10.2

2015-08-19

PREAI

Poggesi, Italo; Sardu, Maria Luisa; Marostica, Eleonora; Sukbuntherng, Juthamas; Chang, Betty Y.; de Jong, Jan; de Trixhe, Xavier Woot; Vermeulen, An; De Nicolao, Giuseppe; O'Brien, Susan Mary; Byrd, John C.; Advani, Ranjana H.; James, Danelle Frances; Deraedt, William; Beaupre, Darrin; Wang, Michael

Tetraspanins as therapeutic targets in hematological malignancy: a concise review

FRONTIERS IN PHYSIOLOGY

IF3.4

2015-03-23

OAAI

Beckwith, Kyle A.; Byrd, John C.; Muthusamy, Natarajan

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2015-03-03

OAAI

Zelenetz, Andrew D.; Gordon, Leo I.; Wierda, William G.; Abramson, Jeremy S.; Advani, Ranjana H.; Andreadis, C. Babis; Bartlett, Nancy; Byrd, John C.; Czuczman, Myron S.; Fayad, Luis E.; Fisher, Richard I.; Glenn, Martha J.; Habermann, Thomas M.; Harris, Nancy Lee; Hoppe, Richard T.; Horwitz, Steven M.; Kelsey, Christopher R.; Kim, Youn H.; Krivacic, Susan; LaCasce, Ann S.; Nademanee, Auayporn; Porcu, Pierluigi; Press, Oliver; Rabinovitch, Rachel; Reddy, Nishitha; Reid, Erin; Saad, Ayman A.; Sokol, Lubomir; Swinnen, Lode J.; Tsien, Christina; Vose, Julie M.; Wilson, Lynn; Yahalom, Joachim; Zafar, Nadeem; Dwyer, Mary; Sundar, Hema

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib

LEUKEMIA

IF13.4

2014-12-09

OAAI

Guinn, D.; Ruppert, A. S.; Maddocks, K.; Jaglowski, S.; Gordon, A.; Lin, T. S.; Larson, R.; Marcucci, G.; Hertlein, E.; Woyach, J.; Johnson, A. J.; Byrd, J. C.

Magnetic Tweezers-Based 3D Microchannel Electroporation for High-Throughput Gene Transfection in Living Cells

SMALL

IF12.1

2014-12-02

OAAI

Chang, Lingqian; Howdyshell, Marci; Liao, Wei-Ching; Chiang, Chi-Ling; Gallego-Perez, Daniel; Yang, Zhaogang; Lu, Wu; Byrd, John C.; Muthusamy, Natarajan; Lee, L. James; Sooryakumar, Ratnasingham

Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma

MABS

IF7.3

2014-10-30

OAAI

Alinari, Lapo; White, Valerie L.; Earl, Christian T.; Ryan, Timothy P.; Johnston, Jeffrey S.; Dalton, James T.; Ferketich, Amy K.; Lai, Raymond; Lucas, David M.; Porcu, Pierluigi; Blum, Kristie A.; Byrd, John C.; Baiocchi, Robert A.

Population pharmacokinetic model of ibrutinib, a Bruton's tyrosine kinase inhibitor, for the treatment of B-cell malignancies

CANCER RESEARCH

IF16.6

2014-10-01

PREAI

Marostica, Eleonora; Sukbuntherng, Juthamas; Loury, David; Jong, Jan D.; de Trixhie, Xavier Woot; Vermeulen, An; de Nicolao, Giuseppe; O'Brien, Susan; Byrd, John C.; Advani, Ranjana; McGreivy, Jesse; Poggesi, Italo

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2014-07-17

1.4K

OAAI

Byrd, J. C.; Brown, J. R.; O'Brien, S.; Barrientos, J. C.; Kay, N. E.; Reddy, N. M.; Coutre, S.; Tam, C. S.; Mulligan, S. P.; Jaeger, U.; Devereux, S.; Barr, P. M.; Furman, R. R.; Kipps, T. J.; Cymbalista, F.; Pocock, C.; Thornton, P.; Caligaris-Cappio, F.; Robak, T.; Delgado, J.; Schuster, S. J.; Montillo, M.; Schuh, A.; de Vos, S.; Gill, D.; Bloor, A.; Dearden, C.; Moreno, C.; Jones, J. J.; Chu, A. D.; Fardis, M.; McGreivy, J.; Clow, F.; James, D. F.; Hillmen, P.

研究方向